课题基金 / 基金详情

Leukemogenesis by Murine Retroviruses

Leukemogenesis by Murine Retroviruses
鼠逆转录病毒引起的白血病
批准号:
6827837
负责人:
JACK R. LENZ
金额:
$37.16万
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-05-01 至 2006-11-30

项目摘要

项目成果

JACK R. LENZ的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Murine leukemia viruses (MuLVs) are potent inducers of hematopoietic tumors in mice. Transcriptional regulatory sequences within the long terminal repeats (LTRs) of these viruses control the expression of the viral genomes and play crucial roles in the process of tumorigenesis by these viruses. They determine the type of tumor that specific MuLVs cause, they influence the ability of the viruses to infect the target cells for disease, and they play a role in the tumorigenic activation of cellular genes following adjacent insertion of the viral genomes. Experiments are proposed here to compare the transcriptional capacity of different MuLVs on templates that are integrated at various sites in the mouse genome. These experiments will use cells from the lineages in which these viruses cause tumors. A second line of experiments is proposed to identify the cellular genes that are activated by these viruses in tumors and to begin to test how these genes participate in tumorigenesis. High-throughput technology is now available that allows such genetic screens to be performed far more rapidly than in the past. This approach will be applied to two separate MuLV tumor systems. The genes that are identified in these screens are expected to provide insight about important and perhaps unanticipated molecular mechanisms that contribute to the generation of leukemias and lymphomas.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a high-resolution mapping platform for HPV DNA integration in premalignant lesions
Development of a high-resolution mapping platform for HPV DNA integration in premalignant lesions
Development of a high-resolution mapping platform for HPV DNA integration in premalignant lesions
IMAT-ITCR Collaboration: Development of a high-resolution mapping platform for HPV DNA integration in premalignant lesions